Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ADVM Adverum Biotechnologies
0.620
-0.012-1.90%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Single Segment--7.5M100.00%
Region Unit:USD
nameYOYOperating income%
United States--7.5M100.00%
Company Overview More
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
CEO: Dr. Laurent Fischer, M.D.
Market: NASDAQ
Listing Date: 07/31/2014
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist